Skip to main content

Table 1 Baseline characteristics of enrolled patients with pathologically proved prostate cancer

From: In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?

Clinicopathologic findings Patients (n = 80)
Age (years; mean, range) 70.7 (59–83)
Serum PSA
 Total PSA 13.09 (1.3–66.2)
 Free PSA 1.70 (0.2–7.2)
Cancer location
 Transition zone 22
 Peripheral zone 44
 Transition and peripheral zone 14
Pathologic T stage
 T2a, T2b 16
 T2c 41
 T3a 13
 T3b 10
Pathologic N stage
N0 76
N1 4
Seminal vesicle invasion  
 No 71
 Yes 9
Extracapsular extension
 No 49
 Yes 31
Gleason score (GS)
 6 6
 7 63
 8-9 11